PercipEnz eyes financials in OnCore software upgrade; CRO Integrium chooses Phase Forward IRT for trial planning;

> Real-time financial data continues to be top of mind for users, says Anthony O'Hare, chief scientist at PercipEnz, in announcing v10.0 of the OnCore clinical and translational research software for academic organizations and cancer centers. Release

> Full-service CRO Integrium, a specialist in running trials for dermatology, cardiovascular and metabolic disease treatments, has signed with Phase Forward for the latter's Interactive Response Technology (IRT) trial planning and management solution. Announcement

> Akaza Research has announced that its OpenClinica Enterprise open-source platform was selected by Taiwanese CRO Qualitix Clinical Research Co for electronic data capture in multi-national trials. Release

> Almac Clinical Technologies has unveiled a reporting solution for its IXRS integrated phone and web response technology. Announcement

> "There are great opportunities for bioinformatics startups to support the onslaught of genomic data," says Rusty Gage of the Salk Institute for Biological Studies, at a life sciences industry forum. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.